Phase II study of cystemustine in metastatic colorectal carcinoma. A trial of the EORTC Clinical Screening Group.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  European Journal of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0959-8049(93)90302-VPMID 8217367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adjuvant and palliative treatments of colon cancer.

  1992cited by this paper
• Lack of value for methyl-CCNU (MeCCNU) as a component of effective rectal cancer surgical adjuvant therapy ; Interimanalysis of intergroup protocol 86-47-51.

  1991cited by this paper
• Chemotherapy in gastrointestinal malignancies.

  1988cited by this paper
• Cytostatic action of two nitrosoureas derived from cysteamine

  1986cited by this paper
• Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.

  1986cited by this paper
• Reporting results of cancer treatment

  1981cited by this paper
• Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.

  1975cited by this paper
• Brief Communication: Therapy of Advanced Colorectal Cancer With a Combination of 5-Flourouracil, Methyl-l,3-cis(2-chlorethyl)-1-nitrosourea, and Vincristine

  1975cited by this paper
• Therapy of advanced gastrointestinal cancer with the nitrosoureas.

  1973cited by this paper
• Therapy of advanced gastrointestinal cancer with the nitrosoureas.

  1973cited by this paper

• Small intestinal protein metabolism during cancer cachexia and chemotherapy in mice

  1999cites this paper